Advanced Appendiceal Cancer with Systematic Metastasis without Gastrointestinal Symptoms Found by Subcutaneous Tumor Internal Medicine. 2023;62(18):2655-2660 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36754410 Attenuated Familial Adenomatous Polyposis Internal Medicine. 2023;62(18):2651-2654 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36725040 Clinicopathological Features and the Prevalence of Oxyntic Gland Neoplasm: A Single-center Retrospective Study Internal Medicine. 2023;62(19):2763-2774 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36792200 Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study Lancet. 2023;402(10406):988-996 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37572680 Diagnosis and Treatment of Cirrhosis JAMA. 2023;330(10):969 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37698572 Diagnosis and Treatment of Cirrhosis-Reply JAMA. 2023;330(10):970 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37698567 Discrepancy between Abdominal Symptoms and Endoscopic Findings in Patients with Gastro-duodenal Eosinophilia: A Case Series Internal Medicine. 2023;62(18):2661-2665 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36754406 Enlargement of the Spleen Index Is a Predictor of the Occurrence of Esophageal Varices and Hepatocellular Carcinoma after Administering Direct-acting Antiviral Agents Internal Medicine. 2023;62(18):2597-2606 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36725036 Gastric outlet obstruction secondary to chronic peptic ulcer disease Lancet. 2023;402(10406):997 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37716771 Hepatitis C Lancet. 2023;402(10407):1085-1096 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37741678 Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study Medical Journal of Australia. 2023;219(5):227-229 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37408320 Impact of body mass index on disease progression and outcomes in patients with nonalcoholic fatty liver disease Postgraduate Medical Journal. 2023;99(1176):1094-1103 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37308443 In moderate-to-severe Crohn disease, upadacitinib increased clinical remission at 12 and 52 wk Annals of Internal Medicine. 2023;176(9):Jc103 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37665995 The Need for Randomized Clinical Trials Demonstrating Reduction in All-Cause Mortality With Blood Tests for Cancer Screening JAMA Intern Med. 2023;183(10):1051-1053 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37639263 Non-erosive reflux disease and oesophageal carcinoma BMJ. 2023;382:1979 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37704257 Pericardial-oesophageal fistula after ablation for atrial fibrillation Lancet. 2023;402(10405):882 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37689411 The price and value of therapeutic synergy in liver cancer Lancet. 2023;402(10408):1108-1110 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37499669 Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH New England Journal of Medicine. 2023;389(11):998-1008 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37356033 Regarding: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis Journal of Internal Medicine. 2023;294(4):536 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37276455 Sarcoidosis or Crohn Disease: Diagnostic Dilemma American Journal of Medicine. 2023;136(10):e206 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37734808 Screening for advanced liver disease in the general population Lancet. 2023;402(10406):941-943 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37572681 Severe TAFRO Syndrome Mimicking Hepatorenal Syndrome Successfully Treated with a Multidisciplinary Approach: A Case Report and Literature Review Internal Medicine. 2023;62(18):2715-2724 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36725034 Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency American Journal of Medicine. 2023;136(10):1011-1017 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37451388 Ulcerative Colitis in Adults: A Review JAMA. 2023;330(10):951-965 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37698559 Underutilisation of gastric emptying studies and underrecognition of gastroparesis in people with diabetes treated in a hospital setting Internal Medicine Journal. 2023;53(9):1697-1700 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37743237 US Hepatitis C Elimination Plan JAMA. 2023;330(9):877-878 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37668627
Advanced Appendiceal Cancer with Systematic Metastasis without Gastrointestinal Symptoms Found by Subcutaneous Tumor Internal Medicine. 2023;62(18):2655-2660
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36754410
Attenuated Familial Adenomatous Polyposis Internal Medicine. 2023;62(18):2651-2654
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36725040
Clinicopathological Features and the Prevalence of Oxyntic Gland Neoplasm: A Single-center Retrospective Study Internal Medicine. 2023;62(19):2763-2774
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36792200
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study Lancet. 2023;402(10406):988-996
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37572680
Diagnosis and Treatment of Cirrhosis JAMA. 2023;330(10):969
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37698572
Diagnosis and Treatment of Cirrhosis-Reply JAMA. 2023;330(10):970
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37698567
Discrepancy between Abdominal Symptoms and Endoscopic Findings in Patients with Gastro-duodenal Eosinophilia: A Case Series Internal Medicine. 2023;62(18):2661-2665
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36754406
Enlargement of the Spleen Index Is a Predictor of the Occurrence of Esophageal Varices and Hepatocellular Carcinoma after Administering Direct-acting Antiviral Agents Internal Medicine. 2023;62(18):2597-2606
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36725036
Gastric outlet obstruction secondary to chronic peptic ulcer disease Lancet. 2023;402(10406):997
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37716771
Hepatitis C Lancet. 2023;402(10407):1085-1096
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37741678
Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study Medical Journal of Australia. 2023;219(5):227-229
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37408320
Impact of body mass index on disease progression and outcomes in patients with nonalcoholic fatty liver disease Postgraduate Medical Journal. 2023;99(1176):1094-1103
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37308443
In moderate-to-severe Crohn disease, upadacitinib increased clinical remission at 12 and 52 wk Annals of Internal Medicine. 2023;176(9):Jc103
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37665995
The Need for Randomized Clinical Trials Demonstrating Reduction in All-Cause Mortality With Blood Tests for Cancer Screening JAMA Intern Med. 2023;183(10):1051-1053
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37639263
Non-erosive reflux disease and oesophageal carcinoma BMJ. 2023;382:1979
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37704257
Pericardial-oesophageal fistula after ablation for atrial fibrillation Lancet. 2023;402(10405):882
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37689411
The price and value of therapeutic synergy in liver cancer Lancet. 2023;402(10408):1108-1110
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37499669
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH New England Journal of Medicine. 2023;389(11):998-1008
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37356033
Regarding: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis Journal of Internal Medicine. 2023;294(4):536
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37276455
Sarcoidosis or Crohn Disease: Diagnostic Dilemma American Journal of Medicine. 2023;136(10):e206
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37734808
Screening for advanced liver disease in the general population Lancet. 2023;402(10406):941-943
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37572681
Severe TAFRO Syndrome Mimicking Hepatorenal Syndrome Successfully Treated with a Multidisciplinary Approach: A Case Report and Literature Review Internal Medicine. 2023;62(18):2715-2724
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36725034
Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency American Journal of Medicine. 2023;136(10):1011-1017
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37451388
Ulcerative Colitis in Adults: A Review JAMA. 2023;330(10):951-965
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37698559
Underutilisation of gastric emptying studies and underrecognition of gastroparesis in people with diabetes treated in a hospital setting Internal Medicine Journal. 2023;53(9):1697-1700
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37743237
US Hepatitis C Elimination Plan JAMA. 2023;330(9):877-878
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37668627